Related Experiment Video
Updated: Sep 25, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Correlation of D-dimer and Outcomes in COVID-19 Patients
Hannah M Nemec1, Allison Ferenczy1, Benjamin D Christie1
1Department of Trauma/Surgical Critical Care, The Medical Center Navicent Health and School of Medicine, 5225Mercer University, Macon, GA, USA.
Insights
Higher D-dimer levels in COVID-19 patients correlate with increased risk of intubation and mortality. Monitoring D-dimer trends can help physicians intervene early to improve patient outcomes.
Area of Science:
- Medical Research
- Infectious Diseases
- Clinical Pathology
Background:
- The COVID-19 pandemic has prompted extensive research into patient outcomes and predictive factors.
- Plasma D-dimer levels are emerging as a significant prognostic indicator in coronavirus disease 2019 (COVID-19) patients.
- Understanding laboratory data correlations is crucial for managing hospitalized COVID-19 cases.
Purpose of the Study:
- To investigate the association between D-dimer levels and clinical outcomes in hospitalized COVID-19 patients.
- To determine if admission and peak D-dimer values correlate with adverse events such as intubation and mortality.
- To explore the potential of D-dimer monitoring for early intervention strategies.
Main Methods:
- Retrospective analysis of 97 inpatient COVID-19 positive patients admitted between March and May 2020.
- Collected and analyzed admission and peak D-dimer values.
- Correlated D-dimer levels with patient outcomes, including intubation and mortality.
Main Results:
- The study included 97 patients with a mean age of 63.2 years.
- Median admission D-dimer was 2.35 ug/mL, and median peak D-dimer was 2.74 ug/mL, with an average time to peak of 3.2 days.
- Patients requiring intubation exhibited significantly higher admission D-dimer levels (3.79 ug/mL) compared to those not intubated (1.62 ug/mL).
Conclusions:
- Elevated admission and peak D-dimer levels are linked to poorer clinical outcomes in COVID-19 patients.
- Higher D-dimer values are associated with increased rates of intubation and mortality.
- Early monitoring of D-dimer trends may facilitate timely medical intervention to prevent severe outcomes.
Background:
The coronavirus disease 2019 (COVID-19) global pandemic has impacted daily life and medical practices around the world. Hospitals are continually making observations about this unique population as it relates to laboratory data and outcomes. Plasma D-dimer levels have been shown to be promising as a prognostic factor for outcomes in COVID-19 patients. This single institution retrospective study investigates the correlation between D-dimer and patient outcomes in our inpatient COVID-19 patient population.
Methods:
COVID-19 confirmed positive patients who were admitted between March 2020 and May 2020 at our hospital were identified. Admission and peak D-dimer values and patient outcomes, including intubation and mortality, were retrospectively analyzed.
Results:
Ninety-seven patients met criteria for inclusion in the study Mean age was 63.2 years, median admission D-dimer 2.35ug/mL, and median peak D-dimer 2.74ug/mL. Average time to peak D-dimer was 3.2 days. Patient's requiring intubation had higher admission D-dimers (3.79ug/mL vs. 1.62 ug/mL).
Discussion:
Higher admission and peak D-dimer values were associated with worsening clinical outcomes, specifically with higher rates of intubation and mortality. Noting D-dimer trends early in a patients' COVID course, regardless of patients' clinical condition, may allow opportunities for physicians to provide early intervention to prevent these outcomes.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Correlations
Cardiomyopathy II: Dilated Cardiomyopathy

